PCM
DCPH

Pinz Capital Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Pinz Capital Management’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-165,835
Closed -$1.54M – 265
2022
Q1 		$1.54M Buy
+165,835
New +$1.41M 0.96% 40

Other funds holding DCPH

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Pinz Capital Management's DCPH Position: Q2 2022 in Review

Pinz Capital Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2022, closing a stake of 165,835 shares — an estimated $1.54M sold.

Pinz Capital Management first reported a position in DCPH in Q1 2022 and held it in 1 quarter. The position peaked at $1.54M in Q1 2022. 128 funds tracked by Wall St. Rank hold DCPH as of Q2 2022.

  • Pinz Capital Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Pinz Capital Management sold 165,835 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2022, an estimated $1.54M.
  • Pinz Capital Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q1 2022 and held it in 1 quarter.
  • Pinz Capital Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $1.54M in Q1 2022.
  • 128 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2022.

Based on Pinz Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.